Controlled medicines are essential in paediatric care yet children everywhere—and especially in low- and middle-income countries—face challenges in accessing controlled medicines for their medical needs and to alleviate serious health-related suffering.
In this episode, Belén Tarrafeta and Hazel Gutiérrez join Josefine Gibson to discuss misconceptions that have led to children’s access being overlooked in research and policy efforts. Together, they highlight the imperative of generating child-specific evidence on access, safety, and use, and they explore what it will take to move from global resolutions to real change for children's equitable access to controlled medicines.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Lancet Group. Innehållet i podden är skapat av The Lancet Group och inte av,
eller tillsammans med, Poddtoppen.
